Navigation Links
Early switch from IV to oral meds is effective for children with acute bone infection
Date:2/12/2009

When treating hospitalized children with acute osteomyelitis--a bacterial bone infection--an early changeover from intravenous (IV) antibiotic delivery to oral antibiotics is just as effective as continuing the IV therapy, according to pediatric researchers.

In addition, the oral drugs are more convenient for children and families, and avoid a major drawback of IV use: increased risk of complications from using central catheters, such as infections or breaks in the catheter.

A study team from The Children's Hospital of Philadelphia analyzed hospital records for nearly 2,000 children treated at 29 U.S. pediatric hospitals between 2000 and 2005. Their report appeared in the February issue of Pediatrics. "There had been previous reports with small numbers of patients suggesting that early transition to oral antibiotics was safe and effective," said study leader Theoklis Zaoutis, M.D., M.S.C.E., an infectious diseases specialist at the Center for Pediatric Clinical Effectiveness of Children's Hospital. "This was the first large study of outcomes to directly compare the two practices."

Acute osteomyelitis annually affects at least one in 5,000 children under age 13 in the United States, and results in one percent of all pediatric hospitalizations. Typically caused by the common bacteria Staphylococcus aureus, osteomyelitis usually appears as a fever with some discomfort in a child's leg or arm resulting from the bone infection. The average age of children with the condition is five years.

The traditional treatment has been to supply antibiotics through a central venous catheter over a four- to six-week period after the child returns home from the hospital. Alternatively, children are first treated with IV antibiotics for less than a week, then sent home with oral antibiotics.

In the current study, some 5 percent of the 1,021 children receiving the prolonged IV antibiotic had to return to the hospital for further
'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Women who drink lots of soda at higher risk for early kidney disease
2. Best Practice Database adds Research Highlighting the Value of Internal Consulting and Early-Stage Commercialization Groups in the Pharmaceutical Industry
3. Pearly Penile Papule Patients Can Successfully Be Treated with Targeted CO2 Technology at La Jolla Cosmetic Surgery Centre
4. The New Crystalens HD Gives Many Baby Boomers and Seniors an Opportunity to See Clearly at All Distances while Reducing or Eliminating the Need for Glasses
5. Zinc May Counter Effects of Alcohol in Early Pregnancy
6. Early Detection Methods for Pancreatic Cancer Urgently Needed: A Statement From the Pancreatic Cancer Action Network
7. GlycoMeds Discovery Yields Early Warning Test for Cancer
8. Regular physical activity linked to better quality of life in early-stage lung cancer survivors
9. Workforce shortages in mammography could threaten early detection rates for breast cancer
10. Umbilical cord protein analysis detects early onset infection
11. Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... reduce differences in incidence, deaths, research...ews) -- Efforts to prevent teens from smoking have... incidence and death rates among adults in the Uni...ost lung cancer cases in the United States. Lung c...s than in whites at all ages. Since the 1970s, pro...
(Date:12/3/2009)...rs linked to diabetes, cardiovascular trouble, ... Breast-feeding, even for just a couple of months...lic syndrome -- a dangerous cluster of heart disea...y appearing online Dec. 3 in the journal Diabetes... (gestational) diabetes, breast-feeding between on...
(Date:12/3/2009)...Protecting Donors, and Blood Safety Key Issues ,...-- Teamsters who work at American Red Cross (ARC) ...strike this morning to protest unfair labor practi...facilities that could imperil the safety of donors...tion the wellbeing of employees. ,, The proble...
(Date:12/3/2009)...ck receives President’s Service Award. , ..., 2009 -- CS3 Technology, a leading professional s... businesses across the country, is pleased to anno...t their company-wide retreat, CS3 recognizes outst...ar, Cindi Kessock earned the President’s Ser...
(Date:12/3/2009)...ies have shown that sleep deprivation can raise bl...ty. Treadmill desks have been show effective in lo...e increasing the quality of sleep. , ...- Two sleep studies illustrating the negative effe...independent conclusions which ignore the relation ...
Breaking Medicine News(10 mins):Health News:Lung Cancer's Racial Gap Narrowing 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 2Health News:Breast-Feeding Can Help Mom's Heart Decades Later 3Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2Health News:CS3 Technology Announces Annual Employee Awards 2Health News:CS3 Technology Announces Annual Employee Awards 3Health News:Treadmill Desks Lower Health Risks Caused by Lack of Sleep 2
... is normally thought that risks of blood clots are...of travel. New research has dispelled this common ... during any form of travel where the duration is m...rmation. This was substantiated when the research ...
...edle phobia or fear of needles can be overcome by ...ley faces according to researchers at the Universi... The researchers say that fear of needles can impa.... The researchers said that decorated needles appe...
...searchers from Columbia University and other insti...tnam War veterans suffer from post-traumatic stres...Now lawmakers, advocates have raised questions abo...al health treatment from the Department of Veteran...
...e Starks take prescription drugs worth $200 every ...to emphysema and heart failure. So, Donna and Grov...deral prescription-drug plan, last December. ...Donna was told by a pharmacist that coverage would...
... you have a brain-crushing headache, you are proba...her than swallowing the regulatory doses of aspiri...sh Executive. The study found that salicylic acid,...s in a curry. Researchers at the Rowett Rese...
...alth Experts have called for a ban on junk foods a...lic institutions to help reduce the rate of diabet...st-growing childhood obesity rate, and obesity is ...ional Diabetes Institute in Melbourne, and Philip ...
Other Medicine News:Health News:American War Veterans Not Receiving Enough Care For PTSD 2Health News:Many American senior citizens fall into the “Doughnut Hole” 2Health News:Many American senior citizens fall into the “Doughnut Hole” 3Health News:Many American senior citizens fall into the “Doughnut Hole” 4
(Date:12/3/2009)...hina, Dec. 3 /PRNewswire-Asia/ -- Simcere Pharmace... SCR ), a leading pharmaceutical company,specializ...ng of branded,generic and proprietary pharmaceutic...od and Drug Administration ("SFDA") has initiated ...regarding human use rabies vaccine (vero,cell) man...
(Date:12/3/2009)...NKI, December 3 After two decades ...their field, Lightlake Therapeutics, experts,have ...nd gene testing,subjects for a trial of a simple, ...alth Organisation has described as a global epidem...hase II trial for the everyday treatment against o...
(Date:12/2/2009).... 2 Reportlinker.com announces tha... catalogue: ,, Cardiac Pacemakers - A World M...m/p0164335/Cardiac-Pacemakers---A-World-Market-Ana...ajor segment in a rapidly expanding cardiovascular...market is characterized by relatively mature condi...
Breaking Medicine Technology:Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 2Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 3Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 4Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 5Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 6Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 7Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 8Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 9Reportlinker Adds Cardiac Pacemakers - A World Market Analysis 10STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 1STEMCELL Technologies Inc Announces Release of Defined Animal Protein Free Maintenance Medium for hESCs and hiPSCs 59424 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 1One Day Management Training Program to be Offered November 18 in Boston Area 59420 2One Day Management Training Program to be Offered November 18 in Boston Area 59420 3One Day Management Training Program to be Offered November 18 in Boston Area 59420 4One Day Management Training Program to be Offered November 18 in Boston Area 59420 5New nanotech sensor developed with medical chemistry applications 14461 1New nanotech sensor developed with medical chemistry applications 14461 2
... Aug. 16 Cancer patients fraught with,flare-ups o...e assistance,in the form of a new easy-to-use oral...ences designed to quickly deliver pain medication....of pain: persistent and,breakthrough. Persistent c...sent for long periods of time, and often most of t...
... Two Presentations on the Topic of Drug Repurposin...rategy, MORRISTOWN, N.J., Aug. 16 Vicus Therapeu...opharmaceutical company, announced today,that Chie...ic Officer,Frederic Young, Ph.D., will each presen...Meeting on Sunday, August 19, 2007. The Meeting is...
Other Medicine Technology:Novel Technology Breaks Through Cancer Pain 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 2Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA 3
The Protract Hip System - Protract Standard Hip Stem
Performa Cemented Stem
Stability Cemented Stem
The Foundation 460 Series Cemented Stem
Medicine Products: